Mad Hedge Technology Letter April 25, 2025 Fiat Lux Featured Trade: (THIS TECHNOLOGY IS A FLOP) (META), (AAPL), (MSFT)
Author Archives: april@madhedgefundtrader.com
Meta (META) cutting staff in its virtual reality and augmented reality divisions means uncertainty about future products originating from these places. The juice has not been worth the squeeze. I think everyone remembers when Founder Mark Zuckerberg had those goofy metaverse commercials depicting him as an avatar when he debuted the company name change from […]
(SUMMARY OF JOHN’S APRIL 16, 2025, WEBINAR) April 18, 2025 Hello everyone TITLE – The Special Chaos Issue PERFORMANCE April +0.95 MTD 2025 year to date = +14.78% Since inception = +766.33% One year return = 75.65% Average annualised return = 50.28% PORTFOLIO REVIEW Risk On (COST) 4/$840-$850 call […]
Global Market Comments April 25, 2025 Fiat Lux Featured Trade: (THE UNITED STATES OF DEBT) (TLT)
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
Mad Hedge Biotech and Healthcare Letter April 24, 2025 Fiat Lux Featured Trade: (DIVIDEND HUNTING IN BEAR COUNTRY) (BMY)
One stock in the pharmaceutical sector has been calling to me lately like a siren song amid market turbulence. I’m talking about Bristol-Myers Squibb Co. (BMY), which has taken a beating in the March-April selloff but is dangling a forward estimated 5% dividend yield while generating a whopping 14% annual free cash flow — tops […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]